EUVIMEDEUVIMED entdecken
Crossref

Elastin-like polypeptide enhances the therapeutic activity of thrombopoietin mimetic peptide

Xiansheng Zhao, Yutuo Zheng, Guosheng Gao, Xiaozhen Xu, Airong Hu, Jingjing Ying

Bioscience, Biotechnology, and Biochemistry · 20.03.2026 · 90 (4) · 535-542

DOI: 10.1093/bbb/zbag014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, online erschienen am 02.02.2026. Verfasst von Xiansheng Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Disease, Ningbo No. 2 Hospital, Ningbo, China. Hauptthemen laut MEDLINE: Thrombopoietin, Elastin, Peptides, Recombinant Fusion Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Ningbo Natural Science Foundation, Zhu Xiu Shan Talent Project of Ningbo No. 2 Hospital, Zhejiang Province Key Clinical Specialty Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombopoietin (TPO) is essential for treating thrombocytopenia, but its clinical use is limited by immunogenicity and short half-life. TMP, a TPO mimetic peptide, addresses these issues but requires fusion with carriers to improve pharmacokinetics. This study developed ELP-TMP fusion proteins (ELP120-2TMP and 2TMP-ELP120) to extend half-life and enhance activity via elastin-like polypeptide (ELP). Results showed EC50 values of 5.81 n m for ELP120-2TMP and 10.88 n m for 2TMP-ELP120, compared to 2.65 n m for recombinant human TPO (rhTPO). At a dose of 600 nmol/kg, ELP120-2TMP resulted in peak platelet counts in mice on day 20, exhibiting a half-life of 22.9 h. Conversely, 2TMP-ELP120 achieved peak platelet counts on day 12, with a half-life of 25.4 h. The half-lives of both fusion proteins were significantly longer than that reported 2TMP alone (1 h). Area under the curve indicated superior platelet stimulation over rhTPO (P < 0.01).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombopoietinElastinPeptidesRecombinant Fusion ProteinsAnimalsHumansMiceHalf-LifePlatelet CountThrombocytopeniaBlood PlateletsElastin-Like Polypeptides

Stichwörter der Autor:innen

elastin-like polypeptidefusion proteinpharmacokineticsplateletthrombopoietin mimetic peptide

Substanzen

ThrombopoietinElastinPeptidesRecombinant Fusion Proteinsthrombopoietin mimetic peptideElastin-Like Polypeptides

Autor:innen und Institutionen

  • Department of Liver Disease, Ningbo No. 2 Hospital, Ningbo, China.
  • Department of Neurosurgery, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Clinical Laboratory, Ningbo No. 2 Hospital, Ningbo, China.
  • Liver Diseases Center, Ningbo Institute of Liver Diseases, Ningbo No. 2 Hospital, Ningbo, China.
  • Department of Pharmacy, Ningbo No. 2 Hospital, Ningbo, China.

Förderung

  • Ningbo Natural Science Foundation
  • Zhu Xiu Shan Talent Project of Ningbo No. 2 Hospital
  • Zhejiang Province Key Clinical Specialty Construction Project
  • Ningbo Medical & Health Brand Discipline

Zitieren

APA

Zhao, X., Zheng, Y., Gao, G., Xu, X., Hu, A., & Ying, J. (2026). Elastin-like polypeptide enhances the therapeutic activity of thrombopoietin mimetic peptide. Bioscience, Biotechnology, and Biochemistry, 90(4), 535-542. https://doi.org/10.1093/bbb/zbag014

Vancouver

Zhao X, Zheng Y, Gao G, Xu X, Hu A, Ying J. Elastin-like polypeptide enhances the therapeutic activity of thrombopoietin mimetic peptide. Bioscience, Biotechnology, and Biochemistry. 2026;90(4):535-542. doi:10.1093/bbb/zbag014

BibTeX
@article{Zhao2026,
  author = {Zhao, Xiansheng and Zheng, Yutuo and Gao, Guosheng and Xu, Xiaozhen and Hu, Airong and Ying, Jingjing},
  title = {Elastin-like polypeptide enhances the therapeutic activity of thrombopoietin mimetic peptide},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2026},
  volume = {90},
  number = {4},
  pages = {535--542},
  doi = {10.1093/bbb/zbag014}
}
Kostenlos starten →